세계의 주사 시장 보고서(2024년)

“Rosacea Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rosacea market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rosacea? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The rosacea market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Erythematotelangiectatic Rosacea; Papulopustular Rosacea; Ocular Rosacea; Phymatous Rosacea
• 2) By Drug Class: Antibiotics; Alpha Agonists; Retinoid; Corticosteroids; Immunosuppressants; Other Drug Classes
• 3) By Mode of Administration: Topical; Oral
• 4) By End-User: Hospitals; Clinics; Retail pharmacies; Online pharmacies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Rosacea is a persistent skin disorder that predominantly impacts the facial area, resulting in redness, flushing, and the development of bumps, typically on the cheeks and nose. It usually emerges in adulthood and is more prevalent among individuals with fair skin. Symptoms of rosacea encompass swollen red bumps, visible blood vessels, and pustule formation.

The primary categories of rosacea include erythematotelangiectatic rosacea, papulopustular rosacea, ocular rosacea, and phymatous rosacea. Erythematotelangiectatic rosacea is characterized as a chronic inflammatory skin condition primarily affecting the face, and its treatment often involves a combination of topical medications. Various classes of drugs, including antibiotics, alpha-agonists, retinoids, corticosteroids, immunosuppressants, and others, can be administered via various routes, such as topical and oral applications. These treatments serve various end-users, including hospitals, clinics, retail pharmacies, and online pharmacies.

The rosacea market research report is one of a series of new reports from The Business Research Company that provides rosacea market statistics, including rosacea industry global market size, regional shares, competitors with a rosacea market share, detailed rosacea market segments, market trends and opportunities and any further data you may need to thrive in the rosacea industry. This rosacea market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rosacea market size has grown rapidly in recent years. It will grow from $1.78 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to growing awareness of rosacea, increasing access to healthcare, rising disposable incomes, government support for rosacea research and treatment, .

The rosacea market size is expected to see strong growth in the next few years. It will grow to $2.76 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to biologic therapies, demand for personalized medicine, aging population, increasing prevalence of comorbidities. Major trends in the forecast period include minimally invasive and non-invasive treatments for rosacea, digital health technologies, rosacea-specific cosmetics, non-invasive therapies.

The increasing prevalence of skin diseases is poised to drive the expansion of the rosacea market in the foreseeable future. Skin diseases encompass a spectrum of medical conditions that affect the skin's appearance, structure, and function, which can involve various skin components. Among these conditions, rosacea, characterized by inflammation and skin problems, may result from different factors, including fungal infections like Candida overgrowth. Furthermore, individuals with rosacea are statistically more prone to developing skin cancers, including hepatic cancer, non-melanoma skin cancer, and breast cancer. For instance, recent data from the American Academy of Dermatology Association, published in April 2022, indicated that approximately 9,500 people in the US receive a skin cancer diagnosis daily. Moreover, according to the Centers for Disease Control and Prevention (CDC), reported in March 2023, the total number of deaths due to fungal infections increased from 5,922 in 2020 to 7,199 in 2021. Hence, the rising prevalence of skin diseases is a driving force behind the growth of the rosacea market.

The growing adoption of telehealth is poised to drive the expansion of the rosacea market in the foreseeable future. Telehealth, which involves the use of digital technologies and communication tools for remote healthcare services, consultations, monitoring, and patient education, has become increasingly prevalent. It empowers patients to access medical care and professional guidance from healthcare providers without the necessity of in-person visits. The growing embrace of telehealth plays a pivotal role in enhancing the management of rosacea. It not only improves healthcare access but also facilitates early intervention, patient education, and treatment adherence. For instance, as of August 2022, data from the Australian Digital Health Agency revealed that over 118.2 million telehealth services were provided to 18 million patients, with more than 95,000 healthcare practitioners utilizing telehealth services during this period. Hence, the escalating adoption of telehealth is a key driver of growth in the rosacea market.

The one of the primary challenges that may hinder the growth of the rosacea market is the persistently low diagnosis rate despite the high prevalence of this condition. The limited diagnosis rate is a significant constraint in the rosacea industry, as it restricts the number of individuals seeking treatment, potentially leading to delayed diagnosis and intervention. The current low diagnosis rate is largely attributed to the lack of awareness and education about rosacea among both healthcare providers and the general population. For example, research from the American Academy of Dermatology reveals that rosacea is significantly underdiagnosed, with prevalence rates ranging from 0.09% to 22.41% among various study groups. Hence, the challenge of low diagnosis rates despite the condition's high prevalence continues to impede the growth of the rosacea market.

The prominent companies in the rosacea market are dedicated to pioneering new products and solutions to maintain their presence in the industry. For example, in June 2022, Galderma S.A., a pharmaceutical company based in Switzerland, introduced EPSOLAY cream, a groundbreaking topical treatment. This cream is the first of its kind to utilize microencapsulated benzoyl peroxide (E-BPO), proven through scientific research to alleviate rosacea-related bumps and blemishes. EPSOLAY Cream leverages Sol-Gel Technology's proprietary patented approach, encapsulating benzoyl peroxide within silica-based microcapsules to establish a protective barrier between the medication and the skin's surface. This innovative method helps reduce the potential irritation and dryness typically associated with traditional benzoyl peroxide treatments.

In March 2022, Novan Inc., a specialty dermatology company based in the United States, completed its acquisition of EPI Health LLC for $27.5 million. This strategic acquisition is expected to empower Novan Inc. in establishing a fully integrated specialty dermatology company. It aims to bolster its presence in the specialty dermatology market and further enrich its product portfolio, particularly in the field of dermatological treatments. EPI Health LLC, a US-based pharmaceutical company, specializes in providing medications for conditions like rosacea, acne, and psoriasis.

Major players in the rosacea market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Galderma S.A., Dr. Reddy's Laboratories Ltd., Lupin Limited, LEO Pharma A/S, Almirall S.A., Supernus Pharmaceuticals Inc., Taro Pharmaceuticals, Mayne Pharma, Aclaris Therapeutics Inc., Sol-Gel Technologies Ltd., Nestle Skin Health S.A., Foamix Pharmaceuticals.

North America was the largest region in the rosacea market in 2023. Asia-Pacific is expected to the fastest-growing region in the forecast period. The regions covered in rosacea report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rosacea market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rosacea market consists of sales of metronidazole, azelaic acid, brimonidine, oxymetazoline and tretinoin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Rosacea Market Characteristics

3. Rosacea Market Trends And Strategies

4. Rosacea Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Rosacea Market Size and Growth

• 5.1. Global Rosacea Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Rosacea Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Rosacea Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Rosacea Market Segmentation

• 6.1. Global Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Erythematotelangiectatic Rosacea
• Papulopustular Rosacea
• Ocular Rosacea
• Phymatous Rosacea
• 6.2. Global Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antibiotics
• Alpha Agonists
• Retinoid
• Corticosteroids
• Immunosuppressants
• Other Drug Classes
• 6.3. Global Rosacea Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Topical
• Oral
• 6.4. Global Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Retail pharmacies
• Online pharmacies

7. Rosacea Market Regional And Country Analysis

• 7.1. Global Rosacea Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Rosacea Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Rosacea Market

• 8.1. Asia-Pacific Rosacea Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Rosacea Market

• 9.1. China Rosacea Market Overview
• 9.2. China Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Rosacea Market

• 10.1. India Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Rosacea Market

• 11.1. Japan Rosacea Market Overview
• 11.2. Japan Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Rosacea Market

• 12.1. Australia Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Rosacea Market

• 13.1. Indonesia Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Rosacea Market

• 14.1. South Korea Rosacea Market Overview
• 14.2. South Korea Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Rosacea Market

• 15.1. Western Europe Rosacea Market Overview
• 15.2. Western Europe Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Rosacea Market

• 16.1. UK Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Rosacea Market

• 17.1. Germany Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Rosacea Market

• 18.1. France Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Rosacea Market

• 19.1. Italy Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Rosacea Market

• 20.1. Spain Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Rosacea Market

• 21.1. Eastern Europe Rosacea Market Overview
• 21.2. Eastern Europe Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Rosacea Market

• 22.1. Russia Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Rosacea Market

• 23.1. North America Rosacea Market Overview
• 23.2. North America Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Rosacea Market

• 24.1. USA Rosacea Market Overview
• 24.2. USA Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Rosacea Market

• 25.1. Canada Rosacea Market Overview
• 25.2. Canada Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Rosacea Market

• 26.1. South America Rosacea Market Overview
• 26.2. South America Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Rosacea Market

• 27.1. Brazil Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Rosacea Market

• 28.1. Middle East Rosacea Market Overview
• 28.2. Middle East Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Rosacea Market

• 29.1. Africa Rosacea Market Overview
• 29.2. Africa Rosacea Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Rosacea Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Rosacea Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Rosacea Market Competitive Landscape And Company Profiles

• 30.1. Rosacea Market Competitive Landscape
• 30.2. Rosacea Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Rosacea Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. GlaxoSmithKline plc
• 31.3. Eli Lilly and Company
• 31.4. Viatris Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Bausch Health Companies Inc.
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Perrigo Company PLC
• 31.9. Galderma S.A.
• 31.10. Dr. Reddy's Laboratories Ltd.
• 31.11. Lupin Limited
• 31.12. LEO Pharma A/S
• 31.13. Almirall S.A.
• 31.14. Supernus Pharmaceuticals Inc.
• 31.15. Taro Pharmaceuticals

32. Global Rosacea Market Competitive Benchmarking

33. Global Rosacea Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Rosacea Market

35. Rosacea Market Future Outlook and Potential Analysis

• 35.1 Rosacea Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Rosacea Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Rosacea Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer